Background: Global analysis of the genome, transcriptome, and proteome is facilitated by the recent development of tools for large-scale, highly parallel analysis. We describe a novel nucleic acid amplification system that generates products by several methods. 3-Ribo-SPIA TM primes cDNA synthesis at the 3 polyA tail, and whole transcript (WT)-Ribo-SPIA primes cDNA synthesis across the full length of the transcripts and thus provides whole-transcriptome amplification, independent of the 3 polyA tail. Methods: We developed isothermal linear nucleic acid amplification systems, which use a single chimeric primer, for amplification of DNA (SPIA) and RNA (Ribo-SPIA). The latter allows mRNA amplification from as little as 1 ng of total RNA. Amplification efficiency was calculated based on the delta threshold cycle between nonamplified cDNA targets and amplified cDNA. The amounts and quality of total RNA and amplification products were determined after purification of the amplification products. GeneChip ® array gene expression profiling and real-time PCR were used to test the accuracy and reproducibility of the method. Quantification of cDNA products (before and after amplification) at the 2 loci along the transcripts was used to assess product length (for evaluation of the 3-initiated Ribo-SPIA) and equal representation throughout the length of the transcript (for evaluation of the whole transcript amplification system, WT-Ribo-SPIA TM ). Results: Ribo-SPIA-based global RNA amplification exhibited linearity over 6 orders of magnitude of tran-
High-density microarray platforms enable highly parallel comprehensive measurements of the components of biological systems, integrating many aspects of a phenotype as determined by the genome, transcriptome, and proteome. The shift in strategy from defined component analysis to global and comprehensive approaches requires sophisticated analyses and multiplexing of the targets being queried and is facilitated by the ability to globally amplify the analytes of choice, and subsequent analysis at addressable loci. NuGEN TM has developed rapid, isothermal linear nucleic acid amplification systems that use a single chimeric primer, DNA polymerase with strand displacement activity and RNase H: SPIA TM (single primer isothermal amplification), a DNA amplification procedure; and Ribo-SPIA TM , an RNA amplification procedure. SPIA amplification was implemented for global genomic DNA amplification and for the amplification of specific genomic sequences and synthetic oligonucleotide DNA targets. Ribo-SPIA is similarly suitable for global and target-specific RNA amplification (1) (2) (3) . Both methods can be used for amplification of highly diverse populations of species, such as global transcriptome amplification.
Ribo-SPIA enables mRNA amplification from as little as 1 ng of total RNA. Procedures for global amplification of all transcripts in both eukaryote and prokaryote total RNA were developed, enabling gene expression profiling and analysis from minute biological samples. The amplification products are single-stranded cDNA suitable for a variety of detection and quantification platforms, including high-and low-density arrays, and solution-phase quantification methods for a variety of quantitative realtime PCR chemistries. The linear amplification of large populations of nucleic acid species is particularly important when sample input is limited, as is commonly encountered in clinical research.
In this study we describe the linearity, sensitivity, and reproducibility of the Ribo-SPIA-based Ovation TM systems for gene expression and profiling. The use of the Ribo-SPIA technology for global amplification of mRNA in biological samples and subsequent quantification of defined sets of transcripts of interest has been validated in a mouse model for study of systemic HIV-1 infection (4 ) . Similarly, the Ovation RNA amplification system has been used for mRNA amplification and transcriptional analysis of pig embryogenesis (5 ) .
Materials and Methods total rna samples
We used Universal Human Reference (UHR) 1 total RNA and HeLa total RNA from Stratagene, human spleen and placenta total RNA from Ambion, and human skeletal muscle total RNA from Clontech. RNA quality was determined with an Agilent Bioanalyzer. PCR primers were purchased from Operon Biotechnologies, Inc., or from Integrated DNA Technologies.
In vitro-prepared transcripts for supplementation experiments were purchased from Affymetrix (GeneChip ® Eukaryotic Poly-A RNA Control Kit).
quantitative pcr
Quantification of DNA targets and amplification of products, as well as cDNA (before and after amplification), were carried out with an ABI PRISM TM 7700 sequence detector (Applied Biosystems) or an MJ Opticon (MJ Research). TaqMan ® Universal PCR Master Mix, No AmpErase ® UNG (Applied Biosystems), or 2ϫ ThermoStart Q-PCR Master Mix (ABgene) and QPCR (SYBR ® Green I) reactions were performed with a Qiagen QuantiTect SYBR Green PCR Kit. The reactions were carried out in 96-well optical reaction plates (ABgene), using the recommended thermocycling program (15 min at 95°C to activate Taq polymerase followed by 40 cycles of 95°C for 15 s and 60°C for 60 s). Primers and probes for quantification of various gene products were designed with Primer Express TM software (Applied Biosystems). Primer and probe sets were selected based on assessment of their amplification efficiency. Amplification efficiency was determined from a calibration curve constructed with serially diluted samples.
Human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene products were quantified by TaqMan quantitative PCR for assessment of amplification efficiency, yield of specific amplification products, and reproducibility of the new amplification system. Both nonamplified and amplified cDNA were interrogated at 2 locations along the gene transcript product, the 3Ј end (at 0.3 kb from the polyA tail) and the 5Ј end (at 1 kb from the polyA tail). The quantification of cDNA products (before and after amplification) at the 2 loci along the transcripts provides a tool for the assessment of product length (an important criterion for evaluation of the 3Ј-initiated Ribo-SPIA) and equal representation throughout the length of the transcript (an important criterion for evaluation of the wholetranscript amplification system, WT-Ribo-SPIA).
SPIA and Ribo-SPIA All amplifications used the Ovation RNA amplification System or Ovation Biotin System (NuGEN Technologies, Inc.), or components thereof, according to manufacturer's instructions (http://www.nugeninc.com).
The quantification of target nucleic acids and amplification, SPIA, and Ribo-SPIA products is expressed as the threshold cycle (Ct) value as determined by real-time PCR (TaqMan or SYBR Green I). Amplification efficiency was calculated based on the delta Ct between nonamplified cDNA targets and amplified cDNA, with added consideration of dilution factors, given the relative differences in cDNA concentration. The sizes of amplification products and of fragmented and biotin-labeled products prepared for array analysis, after fragmentation and biotin labeling, were determined by Lab-on-a-Chip analysis in a Bioanalyzer (Agilent).
The amount and quality of total RNA and amplification products were determined by use of a NanoDrop ® ND-1000 Spectrophotometer (NanoDrop Technologies) after purification of the amplification products. Amounts were calculated with the following formula: 1 A 260 unit ϭ 33 g/mL for DNA and 40 g/mL for RNA.
Nucleic acids were purified with commercial DNA purification reagent sets such as the NucleoSpin
gene expression analysis with GeneChip arrays Targets for GeneChip array gene expression analysis were prepared with the Ovation Biotin reagent set, the WTOvation, or the Affymetrix standard protocol. The fragmented and biotin-labeled cRNA or cDNA targets were hybridized to either HG-U133A or U133A v2 GeneChip arrays, stained with streptavidin-phycoerythrin with antibody amplification, and scanned according to the manufacturer's protocols, except that only 2-2.5 g of Ribo-SPIA cDNA target per array was hybridized (compared with 10 g of cRNA). Denaturation of the cDNA targets for 2 min at 99°C before hybridization was followed by hybridization for 18 -20 h. Array data were analyzed by MAS5 software (Affymetrix).
Ribo-SPIA linearity
The linearity of Ribo-SPIA RNA amplification was demonstrated by quantification of transcripts added to a complex background of total RNA. The in vitro-prepared mixture of 4 transcripts used for assessment of RNA amplification and subsequent analysis by either quantitative PCR or array-based gene expression analysis was from Affymetrix (GeneChip Eukaryotic Poly-A RNA Control Kit). Although not intended for this use, dilution of the transcript mixture into a known amount of total RNA (5 ng of HeLa total RNA in our study) provides a system for the assessment of the linearity and sensitivity of the amplification process. The experimental design was as follows: The transcript mixture was added to a HeLa total RNA sample (5 ng) at various dilutions of the initial mixture, and the number of molecules of each of the 4 added transcripts, as well as its relationship to the total mRNA background, was calculated. The number of each of the added transcripts was calculated from the given concentration. The initial dilution of the mixture was 1:2000 into the RNA background sample and was further diluted to cover an input range of 10 6 (see Figs. 3 and 4 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/ vol51/issue10/). The lowest number of input transcript molecules that could be well detected and quantified after amplification determined the detection limit of the amplification system. As few as 10 transcript molecules in a background of 10 8 sample mRNA molecules are shown to be amplified linearly by the Ribo-SPIA system. PCR primers were designed for quantification of each of the added transcripts in the various HeLa RNA samples. The amplified cDNA of each of the transcripts in the total amplification products was quantified by quantitative PCR (Ct; SYBR Green I). Triplicate independent reactions were carried out for each of the samples on the Ovation Biotin System.
Results and Discussion
A schematic presentation of the Ribo-SPIA RNA amplification method is shown in Fig. 1 . The novel linear and isothermal amplification method comprises steps for cDNA synthesis followed by SPIA-based DNA amplification to generate single-stranded cDNA amplification product.
The initial steps of Ribo-SPIA RNA amplification are directed toward the formation of a unique doublestranded cDNA that is a substrate for subsequent SPIA amplification, which generates multiple copies of singlestranded DNA products complementary to the sample mRNA. First-strand cDNA synthesis is carried out with a chimeric primer comprising a 3Ј DNA portion that can hybridize to the RNA to be amplified and a 5Ј RNA portion. The 5Ј RNA portion is a unique sequence that is not complementary to the sample RNA and does not hybridize to it. The 3Ј DNA portion of the first-strand chimeric primer can be designed to vary in length and composition to accommodate the desired priming specificity. Thus, this portion may be longer when priming from the polyA tail or shorter when designed to prime randomly along the full length of the transcripts (for example, random hexamer). The 5Ј-RNA portion sequence is designed to accommodate the full length of the chimeric amplification primer. Reverse transcriptase is used to generate first-strand cDNA by extension of the partially hybridized chimeric primer along the RNA template. The RNA template is then partially degraded in a heating step that also serves to denature the reverse transcriptase. DNA polymerase is added to the reaction mixture to carry out second-strand cDNA synthesis along the first-strand cDNA product of the first step. RNAdependent DNA polymerase activity elongates the product along the RNA portion of the chimeric primer, forming a double-stranded cDNA with a unique RNA/DNA heteroduplex at one end. This unique product serves as a substrate for the subsequent SPIA DNA amplification step.
The amplification step is initiated by the addition of a reaction mixture containing a chimeric primer, a DNA polymerase with strong strand-displacement activity and RNase H. The RNase H cleaves the RNA portion of the heteroduplex at one end of the double-stranded cDNA, thus generating a unique partial duplex cDNA with a The WT-Ribo-SPIA is similarly carried out except for the first strand-synthesis step, which is carried out with chimeric primer with a randomized 3Ј DNA portion to effect random priming across the full length of the transcript. RT, reverse transcriptase.
single-stranded DNA tail at the 3Ј end of the secondstrand cDNA. This tail is the priming site for the SPIA amplification step. The sequence of the SPIA amplification primer, a chimeric DNA/RNA primer, is complementary to the sequence of the single-stranded 3Ј end of the second-strand cDNA in the partial duplex. This DNA/RNA chimeric primer is composed of a DNA sequence at the 3Ј end and an RNA sequence at the 5Ј end. DNA amplification is carried out by extension of this primer, when hybridized to target DNA, by a DNA polymerase with strand-displacement activity and by cleavage of the RNA portion of the primer in the RNA/ DNA heteroduplex created by primer hybridization to the target by RNase H. Cleavage of the 5Ј RNA portion of the primer annealed at the priming site clears this site for hybridization of a new primer molecule, which is extended along the template DNA by DNA polymerase. Strand-displacement DNA synthesis leads to displacement of the previous primer extension product away from the template DNA. This cycle of primer binding, extension, displacement, and cleavage causes efficient generation of multiple copies of the amplification product. The amplification step is carried out at a constant temperature (between 47 and 50°C). The peak of size distribution (Bioanalyzer) of the single-stranded cDNA amplification products, generated under the reaction conditions used for the 3Ј-initiated Ribo-SPIA procedure, was between 500 and 1000 nucleotides (as shown in Fig. 4 ). Of note, the initiation of primer extension to generate single-stranded DNA amplification product is not dependent on the completion of a previous primer extension step. Thus, multiple primer extension products are generated by multiple DNA polymerase molecules moving along the same template DNA. This process is rapid, efficient, isothermal, and linear. In addition, cleavage of the 5Ј portion of the primer extension product (the amplification product) by RNase H renders it nonamplifiable in the given amplification system, thus eliminating containment requirements, and reduces potential deleterious effects of amplification product contaminating naïve samples, a common cause of false-positive results in tests conducted with PCR amplification systems.
Global RNA amplification using the Ribo-SPIA method can be initiated either from consensus sequences or randomly across all transcripts. The 3Ј polyadenylated tail is commonly used for priming cDNA synthesis by reverse transcription as well as for linear amplification of mRNA by various established procedures. The most commonly used method for RNA amplification and gene expression analysis is that first described by Van Gelder et al. (6 ) and Eberwine et al. (7 ) and further optimized by others (8 ) . A T7-based method is also used by Affymetrix for sample preparation for GeneChip arrays (http://www.affymetrix. com/support/technical/technotes/smallv2_technote.pdf). The use of this method for amplification of RNA from very small samples requires one or more additional rounds of T7-RNA polymerase transcription to generate sufficient amounts of cRNA required for microarraybased analysis. WT-Ribo-SPIA allows comprehensive, linear, global amplification of the total transcriptome in both eukaryotes and prokaryotes and is independent of the presence or absence of the 3Ј polyA tail. To ensure whole-transcript amplification without loss of the 3Ј end, which is likely to occur when using random primers for initiation of first-strand cDNA synthesis, we combined chimeric primers comprising polyT with those comprising random hexamer DNA portions for priming of firststrand cDNA synthesis. This is particularly important for the successful eukaryotic whole-transcript amplification.
characterization of Ribo-SPIA products
The continuous nature of the Ribo-SPIA method, both the 3Ј-and randomly initiated RNA amplification methods, makes it possible to generate microgram amounts of DNA from Ͻ5 ng of total RNA input in ϳ4 h. The generation of targets for gene expression analysis by high-density GeneChip arrays requires further fragmentation and labeling of the amplification products. The Ovation Biotin System provides reagents and protocols for fragmentation and biotin labeling of the amplification products. The cDNA fragmentation and biotin-labeling process requires two 30-min incubation steps, and the entire protocol from total RNA to fragmented, biotin-labeled cDNA targets ready for hybridization to GeneChip arrays can be completed in a single day. Alternatively, direct incorporation of Aminoallyl-dUTP to amplified cDNA enables preparation of Cy3/Cy5-labeled cDNA product ready for hybridization to any of a variety of spotted arrays (not described).
Ribo-SPIA reproducibility, linearity, and reliability
The Ribo-SPIA RNA amplification process for both polyA-and WT-Ribo-SPIA was assessed by quantification of nonamplified (products generated after second-strand cDNA synthesis) and amplified cDNA. Quantification was by quantitative real-time PCR. TaqMan PCR was used for quantification of cDNA products generated by the 3Ј-initiated amplification, and SYBR Green I real-time PCR was used for quantification of cDNA generated by WT-Ribo-SPIA. The absolute yield of amplification products was assessed by spectroscopic measurement of purified products, as described in the Materials and Methods.
The reproducibility of RNA amplification was measured by quantitative PCR and the yield of amplification products by spectrophotometry (see Figs. 1 and 2 in the online Data Supplement). Quantification of the GAPDH gene product was adopted as a routine measure of amplification efficiency, to assess successful amplification across the length of the transcript, and to determine reproducibility of the amplification system across time, reagent lots, and by various users. Primers and probes for quantitative PCR were designed at 2 locations along the transcript: the 3Ј end portion (330 bp from the polyA tail) and the 5Ј portion (1 kb from the polyA tail). Quantification of amplification products obtained from 88 independent 3Ј-Ribo-SPIA amplifications of 20 ng of Universal Human RNA (Stratagene) yielded mean (SD) Ct values of 15.1 (0.5) for the 3Ј location of the human GAPDH transcript and 16.1 (0.5) for the 5Ј location of the transcript. Similar reproducibility was achieved with WTRibo-SPIA (see Fig. 2 in the online Data Supplement). The Ovation Biotin System (3Ј-initiated amplification) routinely generates ϳ7 g of purified amplification products from 5 to 100 ng of total RNA samples (88 independent amplification reactions). Similarly reproducible yield of amplification products is achieved with the WT-Ribo-SPIA (data not shown).
Ribo-SPIA amplification across 6 orders of magnitude provided strong evidence of the linearity and sensitivity of Ribo-SPIA (Fig. 2) . The linear correlation factors of the calculated log 10 of the input number of molecules of the specific transcripts added relative to the obtained Ct value for the 4 added transcripts in the various samples (R 2 ) were 0.995, 0.980, 0.975, and 0.998 for Lys, Phe, Thr, and Dap, respectively (also see Fig. 3 in the online Data Supplement). An example of the linear correlation plot of Ct values and input number of molecules for Lys, which represents the lowest to highest addition, is shown in Fig.  2A (each point represents the mean of the 3 independent amplification reactions).
The accuracy and linearity of the WT-Ribo-SPIA were also assessed. As shown in Fig. 3 , good linear correlation (R 2 ϭ 0.85) was obtained for the quantification (Ct values) of amplified and nonamplified cDNA for HeLa total RNA samples (20 ng input) subjected to WT-Ribo-SPIA amplification. Each of the points in Fig. 3 represents the mean of 4 independent reactions. A total of 27 gene products were quantified in each of the samples (before and after the amplification step) by use of PCR primers designed for quantification at different distances from the 3Ј end of the specific transcripts. It is important to note here that this group of genes consisted of several housekeeping genes and other transcripts, most of which are in the very low transcript abundance range. This group of genes (see Table 1 in the online Data Supplement) was selected for evaluation of the system in the low expression range of transcripts, where gene expression analysis is of particular interest. These results demonstrate the linearity of amplification across the transcript length and a wide range of abundance (ϳ1000-fold of low and medium transcript abundance, as determined by quantification of nonamplified cDNA). Similar results (data not shown) were obtained for the Ovation RNA amplification system, with the exception that the amplification products generated by the 3Ј-initiated Ribo-SPIA method represent the 3Ј portion of the transcriptome (limited to ϳ1.2 kb from the 3Ј end).
Ribo-SPIA for gene expression analysis on Affymetrix high-density GeneChip arrays
Unlike the T7-based RNA amplification systems (IVT) that generate cRNA products, Ribo-SPIA generates singlestranded DNA products. The methods commonly used for the fragmentation of cRNA, as required for efficient hybridization and gene expression analysis by use of oligonucleotide microarrays, are not suitable for cDNA products. In the Ribo-SPIA, fragmentation and end labeling of cDNA amplification products were accomplished by two 30-min, simple reagent addition and incubation steps, which involve enzymatic and chemical reactions. The electrophoretic mobility profile (or size distribution) (A), quantification of cDNA products from amplification of total RNA samples (5 ng of HeLa total RNA) to which mixtures of 4 in vitro-prepared RNA transcripts were added to yield samples with transcript input copy numbers covering 10 orders of magnitude. Amplified cDNA of Lys in vitro-prepared RNA transcript, which represents the lowest of the 4 transcripts tested, was quantified by real-time PCR (SYBR Green I). (B), targets prepared by the Ovation Biotin System from duplicate independent reactions were hybridized to U133A v2 GeneChip arrays, and array signals were calculated by the MAS5 software package.
of amplified products before and after fragmentation and biotin labeling, analyzed on a Bioanalyzer (Agilent), are shown in Fig. 4 . Targets prepared by use of the Ovation Biotin System are suitable for use with high-density GeneChip arrays under the manufacturer-recommended conditions for hybridization; however, this approach uses 2-2.5 g of cDNA target per array compared with 15 g of cRNA target (Affymetrix protocol).
Targets prepared by Ribo-SPIA amplification of small samples of total RNA and the NuGEN fragmentation and biotin-labeling system provide highly reproducible gene expression analysis with the Affymetrix GeneChip array. Reproducible performance of the Ovation-generated targets on human U133A GeneChip arrays, across a range of input total RNA (1-100 ng of total UHR RNA), was demonstrated. The correlations of signals generated on replicate arrays hybridized with independently prepared targets from samples containing 1-100 ng of total RNA (UHR), as well as call concordance (generated by the Affymetrix software package), are shown in Table 1 . Signal correlation (R 2 ) and call concordance were well maintained across the 5-to 100-ng total RNA input range. Targets generated from samples containing 1 ng of input total RNA yielded somewhat lower detection of present calls (expressed as the percentage of genes detected as present) and lower signal correlation coefficients. The signal correlation coefficient for arrays hybridized with targets generated from 1-ng samples compared with target prepared from 100-ng samples was 0.93 compared with 0.97 for arrays hybridized with targets generated from 1 ng of input each. Similar results were observed for call concordance. These results indicate the high reproducibility and array performance of the Ovation Biotin System, which allows single-round target preparation from very small input RNA samples. The simple and rapid target preparation system is easily automated and suitable for high-throughput applications such as in clinical research.
The linearity and accuracy of gene expression profiling by the Ribo-SPIA method for amplification of small total RNA samples and analysis on GeneChip arrays was further demonstrated with samples to which in vitroprepared transcripts were added, as described above. The GeneChip arrays contained probe sets for specific hybridization of targets generated with each of the in vitroprepared transcripts and allowed interrogation at 3 locations along the in vitro-prepared transcripts (3Ј, middle, and 5Ј). This array design further enabled the assessment of amplification linearity and amplification product length (ϳ1.2 kb). The correlation of array signals and transcript input into the sample (log 10 input copy num- The quantification of a set of amplified and nonamplified cDNA products representing 27 gene products quantified at different locations along the transcript length was carried out by real-time PCR (SYBR Green I; Ct values). Each data point is the mean of results from duplicate Ribo-SPIA reactions. Fig. 4 . Bioanalyzer traces for Ribo-SPIA cDNA products before and after fragmentation and biotin labeling.
The internal standard peaks are at 0.2, 0.5, 1, 2, 4, and 6 kb (plus an added oligonucleotide at 19 s).
ber) for the Lys transcript, which includes the lowest input number of added molecules, is shown in Fig. 2B . Each point represents the mean signals from two U133A v2 GeneChip arrays. Signal linearity of the amplified transcripts over a ϳ1000-fold range of transcript copy number input was demonstrated for all 4 transcripts (see Fig. 4 in the online Data Supplement) and reflects the expected lower detection limit of the platform compared with quantitative PCR (shown above). The signals generated across the length of the individual transcript products, as indicated by the 3Ј-, middle-, and 5Ј-located probe sets, were almost identical for the 4 transcripts, indicating the high accuracy of amplification across the length of the transcripts and the compatibility of the Ovation-generated targets from low total RNA input samples with gene expression profiling on GeneChip arrays.
Gene expression profiles obtained with targets prepared with the Ovation Biotin System and HG-U133A GeneChip arrays were comparable to those obtained from the same RNA samples prepared by the Affymetrix standard target protocol. Three independent IVT target preparation reactions of UHR total RNA (Stratagene) run by an independent laboratory starting with 10 g of total RNA per amplification gave a present call of 51.5% Ϯ 1.7%. A total of 13 Ribo-SPIA amplifications with 20 ng of total RNA input per amplification gave a present call of 53.6% Ϯ 2.7%. Call concordance between the 2 methods was 86%. Thus, the 2 methods detect comparable numbers of transcripts.
An important advantage offered by the Ovation RNA amplification and target preparation systems is the generation of single-stranded cDNA products that provide a highly specific hybridization target for oligonucleotide arrays in general and GeneChip arrays in particular. The higher specificity afforded by DNA/DNA hybridization compared with cRNA/DNA heteroduplex formation has been suggested previously (9 -11 ) . This was further verified by analysis of GeneChip array data for the Ovation Biotin System-generated targets (3 ). The high sensitivity and specificity afforded by this single-round amplification method, compared with the standard protocol (higher input of total RNA) and other commercially available 2-round small-sample T7-based protocols (20 ng total RNA input), were reported recently (12 ) . It should be noted that highly accurate gene expression profiling from nanogram amounts of input total RNA by optimized protocols for 2 rounds of T7-based amplification was achieved (13 ) .
The performance of targets generated by WT-Ribo-SPIA and the NuGEN fragmentation and biotin-labeling reagents and protocols, on U133A v2 GeneChip arrays, is summarized in Table 2 . Targets were prepared from HeLa total RNA samples (20 ng) and applied to the GeneChip arrays by the same procedure as target prepared with the Ovation Biotin System. As shown in Table 2 , array performance and signal reproducibility (R 2 ) were very similar for the 2 Ribo-SPIA RNA amplification and target preparation methods, as would be expected given the design of the array (biased toward the 3Ј portion of the transcripts). However, we expect that the WT-Ribo-SPIA RNA amplification system will be more suitable for gene expression analysis of the full length of the transcripts (whole-transcript amplification) and provide a new tool for transcriptome analysis from small samples, thus enabling analysis of the full transcriptome repertoire, encompassing all splice variants. differential gene expression analysis using the Ribo-SPIA rna amplification method Differential gene expression analysis is a criterion most relevant for most applications in which global changes in transcriptome composition are analyzed. Accurate determination of differential gene expression in small samples requires highly reproducible linear RNA amplification or sample preparation. These requirements are particularly The linearity of the Ovation RNA amplification system was evaluated by determination of differential gene expression between total RNA samples, UHR (reference human RNA), and human skeletal muscle (each at 20 ng of total RNA). The amounts of 40 gene products (see Table  2 in the online Data Supplement) were determined by TaqMan PCR in the nonamplified and amplified cDNA. Differential expression between the 2 RNA samples was determined (expressed as the difference in Ct). The linear relationship for log 2 of relative expression before or after amplification (expressed as difference in Ct) over a range of nearly 20 Ct, or 6 orders of magnitude, was excellent with a correlation coefficient (R 2 ) of 0.97 (Fig. 5) . Thus, Ribo-SPIA provides a reliable representation of changes in transcript abundance in nonamplified mRNA.
We also evaluated differential gene expression determined with the Ovation Biotin system and GeneChip arrays. The results obtained from replicate independent samples (human liver and UHR at 20 ng of total RNA input each) prepared with the Ovation Biotin System amplification and target systems were compared with those obtained by the standard T7-based protocol using higher input of the same total RNA samples. The correlation coefficients (R 2 ) obtained were 0.94 for the reproducibility of the Ovation Biotin System and the standard T7 protocol and 0.83 for the comparison between the 2 methods. These results demonstrate the accuracy of the Ovation RNA amplification system relative to the commonly used target preparation method, which is carried out with ϳ100-fold more total RNA per sample (standard protocol).
Conclusions
The Ribo-SPIA isothermal linear RNA amplification systems are highly reproducible and sensitive (5-100 ng of total RNA input), fast, and simple to operate. Both wholetranscript amplification and 3Ј-initiated RNA amplification reproducibly generate high-quality cDNA amplification products suitable for transcriptome analysis on highdensity oligonucleotide arrays (GeneChip arrays) or for real-time quantitative PCR (TaqMan or SYBR Green I). These systems provide a means for global gene expression analysis from very small samples and should be particularly useful for clinical research in which supplies of biological samples are limited. In addition, this protocol makes these methods suitable for RNA amplification of all samples irrespective of RNA amount.
Comprehensive amplification of sample transcriptome for the generation of targets suitable for large-scale gene expression analysis has been achieved. The Ribo-SPIA system is highly sensitive while maintaining reliable amplification and linearity, and it enables gene expression profiling of minute amounts (5-100 ng) of total RNA. The simple "add and incubate" protocol makes the method suitable for automation, which is of great advantage for high-throughput applications. Most importantly, the use of a single method for all samples streamlines acquisition of gene expression data across all samples. 
